The AHA appreciates the opportunity to comment on the Drug Enforcement Administration’s proposed notice on aggregate production quotas for schedule I and II controlled substances.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
AHA's input on the Health Resources and Services Administration’s Rural Access to Health Care Services request for information (RFI). The RFI solicits comments on access to care in rural areas.
AHA urges the Medicare Payment Advisory Commission to release a “more granular assessment of the hospital-level impacts” of its potential changes to the Indirect Medical Education program.
In a letter to Representatives Peter Welch and David B. McKinley:The AHA expresses support for H.R. 4538, the Closing Loopholes for Orphan Drugs Act.
The AHA appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ hospital outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year 2020.
The AHA supports a number of proposed policy changes that ensure access to care, support public health efforts, improve quality and promote regulatory relief. Specifically, we strongly support CMS’s proposed reversal of its previously finalized policies for evaluation and management payments.
The AHA expressed concerns with the Fairness for High-Skilled Immigrants Act (S. 386/H.R.1044), legislation that would eliminate the per-country cap for immigrant visas.
The AHA has developed a model comment letter that hospitals and health systems can use to submit comments to CMS about these proposals. Download the letter and use it to submit your comments to CMS by Sept. 27.
AHA comments on provisions of surprise medical billing legislation passed in July by the Energy and Commerce Committee, as we understand your Committee may be interested in considering a similar ap
The AHA appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ specialty care models proposed rule, and specifically on the radiation oncology (RO) model. As described in the proposed rule, the RO model would test whether prospective, bundled payments for 90-day radiotherapy (RT) episodes of care would reduce Medicare spending while preserving or improving the quality of care for Medicare beneficiaries.